The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Yamamoto, Ryuji
    Company Director born in March 1942
    Individual (1 offspring)
    Officer
    2011-04-20 ~ dissolved
    OF - director → CIF 0
    Mr Ryuji Yamamoto
    Born in March 1942
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Mccarthy, Alun Daniel
    Director born in March 1956
    Individual (1 offspring)
    Officer
    2007-05-10 ~ dissolved
    OF - director → CIF 0
    Mccarthy, Alun Daniel
    Director
    Individual (1 offspring)
    Officer
    2007-05-10 ~ dissolved
    OF - secretary → CIF 0
Ceased 6
  • 1
    Hashimoto, Kozo, Dr
    Company Director born in March 1952
    Individual
    Officer
    2007-05-10 ~ 2010-04-01
    OF - director → CIF 0
  • 2
    Delrieu, Olivier Georges Jean-pierre
    Head Clinical Sciences born in June 1970
    Individual
    Officer
    2009-07-17 ~ 2018-06-06
    OF - director → CIF 0
  • 3
    Walker, David Graeme
    Clinical Development Dir born in September 1960
    Individual
    Officer
    2009-07-17 ~ 2011-03-31
    OF - director → CIF 0
  • 4
    Fujita, Yoshiji
    Business Management born in February 1948
    Individual
    Officer
    2009-07-17 ~ 2011-04-20
    OF - director → CIF 0
  • 5
    41 Chalton Street, London
    Dissolved corporate (5 parents, 129 offsprings)
    Equity (Company account)
    1 GBP2021-12-31
    Officer
    2007-05-10 ~ 2007-05-10
    PE - nominee-secretary → CIF 0
  • 6
    41 Chalton Street, London
    Dissolved corporate (5 parents, 237 offsprings)
    Equity (Company account)
    1 GBP2021-12-31
    Officer
    2007-05-10 ~ 2007-05-10
    PE - nominee-director → CIF 0
parent relation
Company in focus

PHARMACOGENOMIC INNOVATIVE SOLUTIONS LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Cash at bank and in hand
2,406 GBP2020-05-31
3,444 GBP2019-09-30
Creditors
Current
2,700 GBP2020-05-31
2,700 GBP2019-09-30
Net Current Assets/Liabilities
-294 GBP2020-05-31
744 GBP2019-09-30
Total Assets Less Current Liabilities
-294 GBP2020-05-31
744 GBP2019-09-30
Equity
Called up share capital
125,001 GBP2020-05-31
125,001 GBP2019-09-30
Retained earnings (accumulated losses)
-125,295 GBP2020-05-31
-124,257 GBP2019-09-30
Equity
-294 GBP2020-05-31
744 GBP2019-09-30
Other Creditors
Current
2,700 GBP2020-05-31
2,700 GBP2019-09-30

  • PHARMACOGENOMIC INNOVATIVE SOLUTIONS LIMITED
    Info
    Registered number 06242578
    Grove House Grove House, Manor Close, Penn, High Wycombe, Buckinghamshire HP10 8HZ
    Private Limited Company incorporated on 2007-05-10 and dissolved on 2021-04-13 (13 years 11 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.